{"id":"W3137566103","doi":"10.1016/j.eururo.2021.02.041","title":"Untangling the PROfound Trial for Advanced Prostate Cancer: Is There Really a Role for Olaparib?","year":2021,"lang":"en","type":"editorial","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"Queen's University","funders":"Arnold Ventures","keywords":"Olaparib; Medicine; PARP inhibitor; Prostate cancer; Homologous recombination; Oncology; Clinical endpoint; Internal medicine; Prostate; Gene; Cancer; Randomized controlled trial; Poly ADP ribose polymerase; Genetics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001028375,0.0004568307,0.0008191899,0.00009874948,0.0003643369,0.00009139173,0.0004125107,0.0003738567,0.00009445205],"category_scores_gemma":[0.001159288,0.0002934665,0.0003975574,0.000169366,0.0002037859,0.00005135327,0.000172155,0.0009752816,0.00002260068],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002343695,"about_ca_system_score_gemma":0.001892601,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004543693,"about_ca_topic_score_gemma":0.00009603818,"domain_scores_codex":[0.9967882,0.0003796156,0.0005388463,0.0009552965,0.000478848,0.0008591973],"domain_scores_gemma":[0.9965224,0.001411361,0.0003417842,0.0006963119,0.0008736397,0.000154502],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.1211557,0.0001626314,0.00002504561,0.0004363869,0.0007378626,0.000135138,0.001023128,0.000006057773,0.0002062839,0.00002791906,0.8576482,0.01843565],"study_design_scores_gemma":[0.07769495,0.00473389,0.00001637741,0.0001344455,0.0006444109,0.000005082113,0.0001517541,0.00003939464,0.0001869113,0.0001519943,0.9159912,0.0002495945],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"editorial","genre_gemma":"editorial","genre_scores_codex":[0.008654294,0.0511746,0.00009594277,0.01732115,0.8894759,0.01992154,0.003855327,0.0002362261,0.009265001],"genre_scores_gemma":[0.001822087,0.008146956,0.0003066824,0.001013615,0.9247622,0.004066827,0.003885001,0.000416721,0.05557985],"genre_candidate":"editorial","genre_consensus":"editorial","teacher_disagreement_score":0.05834302,"threshold_uncertainty_score":0.9999517,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02221300169980072,"score_gpt":0.3445303999727195,"score_spread":0.3223173982729188,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}